NUTRANCT06831331
Nutrition in Rheumatoid Arthritis
StatusEnrolling by Invitation
PhaseNot applicable
SponsorVastra Gotaland Region
Primary completion (estimated)
At risk: Primary endpoint(s) modified, enrollment reduced 20%.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary endpoint(s) modified Show 5 more changesShow less
- Enrollment reduced: 150 → 120 participants
- Interventions modified
- Secondary endpoints revised (13)
- Study description shortened, about 326 words
- Eligibility criteria expanded, about 1 word
- Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
- Secondary endpoints: details revised at 2 of 13 entries
- Site contact updated
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Apolipoprotein B
Timeframe: 3 months dietary intervention and at 9 months follow up
Secondary (13)
Patterns of serum inflammatory markers
Remission yes/no
Disease activity DAS28-CRP
triacylglycerides
high density lipoprotein
Show 8 moreShow less
Low density lipoprotein (LDL)
total cholesterol
Erythrocyte sediment rate (ESR)
high sensitive-C-reactive protein (hs-CRP)
Corticosteroid use
Physical disability
Quality of life (RAND-SF36)
Disease activity score DAS28-ESR
Arms and interventions
Immediate healthy diet intervention based on the NNR 2023Experimental
Diet following the Nordic Nutrition Recommendations 2023
Delayed dietary intervention based on the NNR2023 (waiting-list control)Experimental
Habitual diet for 3 months followed by healthy diet based on NNR2023 for 3 months
Other: Healthy diet based on NNR2023, Control/waiting-list
Sites
1 site in 1 country
- Klinisk Reumatologiskt Forskningscentrum, Sahlgrenska University HospitalGothenburg, Sweden